This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Aptose Biosciences Inc.
Has entered into an amended and restated arrangement agreement, pursuant to which Aptose will continue from the Canada Business Corporations Act to the Business Corporations Act (Alberta) and subsequently be acquired by HS North America Ltd., a wholly owned subsidiary of Hanmi Pharmaceutical Co. Aptose Biosciences Inc. shares T.APS are trading up $0.10 at $2.30.
